Alert

Recommended Alerts

Sign Up For Alerts

SEC Charges Life Sciences Company with Regulation FD Violations

On August 20, 2019, the SEC settled charges against TherapeuticsMD, a Florida-based life sciences company, for violating Regulation FD by selectively communicating to sell-side analysts information about meetings with FDA.

Read More

Supreme Court Rejects Bright-Line Test For Materiality in Rule 10b-5 Class Action With Respect to Adverse Event Reports

Practices: Life Sciences, Corporate & Securities Litigation, Securities & Public Companies

Printer-Friendly Version

Cookie Settings